Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review

Abstract

Traditionally, probiotics are linked to the good health of the intestine and most clinical studies focus on that field. Evidence of oral probiotic use for ear and oral cavity disease prevention with impact on human health is limited. This work reviews existing studies and literature on Streptococcus salivarius K12 as an oral probiotic and effects of S. salivarius K12 on human ear and oral cavity human health. The studies were accessed via database searches: MEDLINE, PubMed, and Elsevier. The search included/focused on/encompassed publications from 2003 to 2016 with keywords related to K12 Streptococcus salivarius, bacteriocin-like inhibitory substances (BLIS) K12, probiotic K12 salivarius, and K12 probiotic health effects. Only a small amount of studies was identified: the total of 68 studies was identified, 35 of which were relevant after screening, and 9 were included in the final analysis. Very little literature is available about the association/correlation between/connection/interrelation of S. salivarius K12 with/and human ear and oral cavity health. S. salivarius K12 may have a role in reducing the occurrence and/or severity of secretory otitis media (SOM) and also in prevention of streptococcal and viral pharyngotonsillitis in children. Research highlights that S. salivarius K12 has shown promising results in treatment of halitosis, but data are still deficient. Further studies need to be initiated to improve understanding of the association of oral probiotic S. salivarius K12 with human ear and oral cavity health.

This is a preview of subscription content, log in to check access.

Figure 1

References

  1. 1.

    Ma F, Zhou C, Wang J, Liu T, Liu J (2015) Probiotics in the treatment of peptic ulcer infected by Helicobacter pylori and its safety. Pak J Pharm Sci 28:1087–1090 http://www.ncbi.nlm.nih.gov/pubmed/26051728

    Google Scholar 

  2. 2.

    Reid G, Dols J, Miller W (2009) Targeting the vaginal microbiota with probiotics as a means to counteract infections. Curr Opin Clin Nutr Metab Care 12:583–587

    Article  Google Scholar 

  3. 3.

    Borchert D, Sheridan L, Papatsoris A, Faruquz Z, Barua JM, Junaid I, Pati Y, Chinegwundoh F, Buchholz N (2008) Prevention and treatment of urinary tract infection with probiotics: review and research perspective. Indian J Urol 24:139–144

    CAS  Article  Google Scholar 

  4. 4.

    Fuchs-Tarlovsky V, Marquez-Barba MF, Sriram K (2016) Probiotics in dermatologic practice. Nutrition 32:289–295

    Article  Google Scholar 

  5. 5.

    Food and Agriculture Organization of the United Nations/ World Health Organization (FAO/WHO) (2002) Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO expert group on drafting guidelines for the evaluation of probiotics in food

  6. 6.

    Hye-Ji K, Sin-Hyeog I (2015) Probiotics as an immune modulator. J Nutr Sci Vitaminol 61:S103–S105

    Article  Google Scholar 

  7. 7.

    Britton RA, Versalovic J (2008) Probiotics and gastrointestinal infections. Interdiscip Perspect Infect Dis 2008:290769

    Article  Google Scholar 

  8. 8.

    Smith DJ, Anderson JM, King WF, van Houte J, Taubman MA (1993) Oral streptococcal colonization of infants. Oral Microbiol Immunol 8:1–4 http://www.ncbi.nlm.nih.gov/pubmed/8510978

    Article  Google Scholar 

  9. 9.

    Wescombe PA, Tagg JR (2012) Developing oral probiotics from Streptococcus salivarius. Future Microbiol 7:1355–1371

    CAS  Article  Google Scholar 

  10. 10.

    Cosseau C, Devine DA, Dullaghan E, Gardy JL, Chikatamarla A, Gellatly S, Yu LL, Pistolic J, Falsafi R, Tagg J, Hancock RE (2008) The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect Immun 76:4163–4175

    CAS  Article  Google Scholar 

  11. 11.

    Hyink O, Wescombe PA, Upton M, Ragland N, Burton JP, Tagg JR (2007) Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12. Appl Environ Microbiol 73:1107–1113

    CAS  Article  Google Scholar 

  12. 12.

    Burton JP, Wescombe PA, Moore CJ, Chilcott CN, Tagg JR (2006) Safety assessment of the oral cavity probiotic Streptococcus salivarius K12. Appl Environ Microbiol 72:3050–3053

    CAS  Article  Google Scholar 

  13. 13.

    Saxelin M, Tynkkynen S, Mattila-Sandholm T, de Vos WM (2005) Probiotic and other functional microbes: from markets to mechanisms. Curr Opin Biotechnol 16:204–211

    CAS  Article  Google Scholar 

  14. 14.

    Coyte PC, Asche CV, Elden LM (1999) The economic cost of otitis media in Canada. Int J of Pediatr Otorhinolaryngol 49:27–36

    CAS  Article  Google Scholar 

  15. 15.

    Burrows HL, Blackwood RA, Cooke JM, Harrison RV, Passamani PP (2013) Otitis media guideline team. University of Michigan Health System, Otitis media guideline

    Google Scholar 

  16. 16.

    Rosenfeld RM, Schwartz SR, Pynnonen MA, Tunkel DE, Hussey HM, Fichera JS, Grimes AM et al (2013) Clinical practice guideline: tympanostomy tubes in children. Otolaryngol Head Neck Surge 149:S1–S35. doi:10.1177/0194599813487302

    Article  Google Scholar 

  17. 17.

    Loos BG, Bernstein JM, Dryja DM, Murphy TF, Dickinson DP (1989) Determination of the epidemiology and transmission of nontypable Haemophilus influenzae in children with otitis media by comparison of total genomic DNA restriction fingerprints. Infect Immun 57:2751–2757 Available at: http://iai.asm.org/content/57/9/2751.abstract

    CAS  Google Scholar 

  18. 18.

    Worrall G (2007) Acute otitis media. Can Fam Physician 53:2147–2148

    Google Scholar 

  19. 19.

    Bollen CM, Beikler T (2012) Halitosis: the multidisciplinary approach. Int J Oral Sci 4:55–63

    CAS  Article  Google Scholar 

  20. 20.

    Gokdogan O, Catli T, Ileri F (2015) Halitosis in otorhinolaryngology practice. Iran J Otorhinolaryngol 27:145–153

    Google Scholar 

  21. 21.

    Hughes FJ, McNab R (2008) Oral malodour—a review. Arch Oral Niol 53:1–7 Available at: http://www.sciencedirect.com/science/article/pii/S0003996908700025

    Article  Google Scholar 

  22. 22.

    Murray RC, Chennupati SK (2012) Chronic streptococcal and non-streptococcal pharyngitis. Infect Disord Drug Targets 12:281–285

    CAS  Article  Google Scholar 

  23. 23.

    Bonsignori F, Chiappini E, De Martino M (2010) The infections of the upper respiratory tract in children. Int J Immunopathol Pharmacol 23:16–19

    CAS  Google Scholar 

  24. 24.

    Vicedomini D, Lalinga G, Lugli N, D'Avino A (2014) Diagnosis and management of acute pharyngotonsillitis in the primary care pediatrician’s office. Minerva Pediatr 66:69–76 Available at: http://pesquisa.bvsalud.org/portal/resource/pt/mdl-24608583

    CAS  Google Scholar 

  25. 25.

    van Zon A, van der Heijden GJ, van Dongen TM, Burton MJ, Schilder AG (2013) Antibiotics for otitis media with effusion in children. Clin Otolaryngol 38:54–55

    Article  Google Scholar 

  26. 26.

    Haukioja A (2010) Probiotics and oral health. Eur J Dent 4:348–355 Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897872/

    Google Scholar 

  27. 27.

    Ljungh A, Wadström T (2009) Lactobacillus molecular biology: from genomics to probiotics. Biotechnol J 4:283–283

    Article  Google Scholar 

  28. 28.

    Jain P, Sharma P (2012) Probiotics and their efficacy in improving oral health: a review. J Appl Pharm Sci 2:151–163 Available at: http://www.japsonline.com/admin/php/uploads/713_pdf.pdf

    Google Scholar 

  29. 29.

    Di Pierro F, Donato G, Fomia F, Adami T, Careddu D, Cassandro C, Albera R (2012) Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent accute otitis media. Int J Gen Med 5:991–997 Available at. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516470/

    Article  Google Scholar 

  30. 30.

    Di Pierro F, Colombo M, Zanvit A, Risso P, Rottoli SA (2014) Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children. Drug Healthc Pat Saf 6:15–20 Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928062/

    Article  Google Scholar 

  31. 31.

    Gregori G, Righi O, Risso P, Boiardi G, Demuru G, Ferzetti A, Galli A et al (2016) Reduction of group a beta-hemolytic streptococcus pharyngo-tonsillar infections associated with use of the oral probiotic streptococcus salivarius k12: a retrospective observational study. Ther Clin Risk Manag 12:87–91 Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725641/

    Article  Google Scholar 

  32. 32.

    Di Pierro F, Adami T, Rapacioli G, Giardini N, Streitberger C (2013) Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults. Expert Opin Biol Ther 13:339–343 Available at: http://www.ncbi.nlm.nih.gov/pubmed/23286823

    CAS  Article  Google Scholar 

  33. 33.

    Burton JP, Chilcott CN, Moore CJ, Speiser G, Tagg JR (2006) A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol 100:754–764 Available at: http://www.ncbi.nlm.nih.gov/pubmed/16553730

    CAS  Article  Google Scholar 

  34. 34.

    Masdea L, Kulik EM, Hauser-Gerspach I, Ramseier AM, Filippi A, Waltimo T (2012) Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour. Arch Oral Biol 57:1041–1047 Available at: http://www.ncbi.nlm.nih.gov/pubmed/22405584

    CAS  Article  Google Scholar 

  35. 35.

    Power DA, Burton JP, Chilcott CN, Dawes PJ, Tagg JR (2008) Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12. Eur J Clin Microbiol Infect Dis 27:1261–1263 Available at: http://www.starmel.com/userfiles/bactoblis/Power_DA_et_al_Preliminary_investigations_of_the_colonissation_of_upper_respiratory_tract_tissues_of_infants_Eur_J_Clin_Microbiol_Infect_Dis_2008.pdf

    CAS  Article  Google Scholar 

  36. 36.

    Walls T, Power D, Tagg J (2003) Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media? J Med Microbiol 52:829–833 Available at: http://jmm.microbiologyresearch.org/content/journal/jmm/10.1099/jmm.0.05259-0#tab2

    CAS  Article  Google Scholar 

  37. 37.

    Di Pierro F, Di Paquale D, Di Cicco M (2015) Oral use of Streptococcus salivarius K12 in children with secretory otitis media: preliminary results of a pilot, uncontrolled study. Int J Gen Med 15:303–308 Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576902/

    Article  Google Scholar 

  38. 38.

    Yaegaki K, Coil JM (2000) Examination, classification, and treatment of halitosis: clinical perspectives. J Can Dent Assoc 66:257–261

    CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Katarina Zupancic.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zupancic, K., Kriksic, V., Kovacevic, I. et al. Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review. Probiotics & Antimicro. Prot. 9, 102–110 (2017). https://doi.org/10.1007/s12602-017-9261-2

Download citation

Keywords

  • Streptococcus salivarius K12
  • BLIS K12
  • Otitis media
  • Oral health